Form 4 · GILD
Gilead Chairman & CEO Daniel Patrick O'Day reports selling 112,429 shares under a 10b5-1 plan
Daniel Patrick O'Day, Gilead's Chairman & CEO and a director, filed a Form 4 on Nov 6, 2026 at 5:15 PM ET reporting transactions between Nov 4, 2026 and Nov 5, 2026.
The filing reports 112,429 shares in an open-market or private sale (code S) at prices from $175.16 to $175.17, about $19.7 million in total; and 112,429 shares in an exercise or conversion of a derivative security (code M).
The filing says the sales were made under a Rule 10b5-1 trading plan adopted February 25, 2026.
After these transactions, the filing lists 551,683 shares held directly.
Reporting person
- Daniel Patrick O'Day, Chairman & CEO and a director (as filed: O'Day Daniel Patrick)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-04 | M | Common Stock | 102,619 | $72.34 | Acquired | 654,302 | Direct |
| 2026-11-04 | S | Common Stock | 102,619 | $175.16 | Disposed | 551,683 | Direct |
| 2026-11-05 | M | Common Stock | 9,810 | $72.34 | Acquired | 561,493 | Direct |
| 2026-11-05 | S | Common Stock | 9,810 | $175.17 | Disposed | 551,683 | Direct |
| 2026-11-04 | M | Non-qualified Stock Option (Right to Buy) (derivative) | 102,619 | Disposed | 138,120 | Direct | |
| 2026-11-05 | M | Non-qualified Stock Option (Right to Buy) (derivative) | 9,810 | Disposed | 128,310 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 6, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Gilead company file → · More Gilead filings
Disclosures
- Editor holdings in GILD
- The editor holds no position in Gilead (GILD). As of Nov 11, 2026.
- Last updated
- Nov 6, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold GILD.